Cannabidiol use in women with endometriosis and chronic pelvic pain: evaluation in pain and quality of life

Phase 3

Recruiting

• Conditions: C13.351.500.163; Endometriosis, pelvic pain

• Registration Number: RBR-6ryrpjs
• Lead Sponsor: nifesp - Universidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-28
• Study Completion: 2021-11-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Patients diagnosed with endometriosis, with an suggestive image exam, who maintain pain (visual analogue scale more than 5) even in the course of drug treatment with hormonal contraceptives for at least 3 months before the inclusion of the study

Exclusion Criteria

Other types of clinical hormonal treatment (anastrozole, gestrinone, GnRh analogue); patients undergoing complementary treatment with physiotherapy, acupuncture, meditation; patients using other herbal medicines (Uncaria tomentosa); patients planning to become pregnant, pregnant and / or lactating women; patients with allergies to medication components; patients with psychiatric disorders; patients with liver disease, heart disease and / or kidney disease; patients taking medications with potential interactions (clonazepam, n-desmethylclobazam, topiramate, stiripentol, zonizamide, eslicarbazepine, rufinamide)

Study & Design

• Study Type: Intervention
• Study Design: Not specified